share_log

4: Statement of changes in beneficial ownership of securities-Officer Mortenson Mark

4: Statement of changes in beneficial ownership of securities-Officer Mortenson Mark

4:持股變動聲明-高管 Mortenson Mark
美股SEC公告 ·  08/20 04:23
牛牛AI助理已提取核心訊息
Mark Mortenson, the Chief Science Officer of Clene Inc. [CLNN], has engaged in a transaction involving the company's stock. The action took place on 08/16/2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Mortenson after the transaction was not provided. Investors are advised to seek further details when considering this event in their investment decisions.
Mark Mortenson, the Chief Science Officer of Clene Inc. [CLNN], has engaged in a transaction involving the company's stock. The action took place on 08/16/2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Mortenson after the transaction was not provided. Investors are advised to seek further details when considering this event in their investment decisions.
Clene公司的首席科學官Mark Mortenson已涉及公司股票的交易。該交易發生在2024年08月16日。然而,公告未透露交易的股份數量、股份性質、交易價格或股份總價值。此外,交易後Mortenson持有股份的數量也未提供。投資者在考慮做出投資決策時應尋求進一步的細節。
Clene公司的首席科學官Mark Mortenson已涉及公司股票的交易。該交易發生在2024年08月16日。然而,公告未透露交易的股份數量、股份性質、交易價格或股份總價值。此外,交易後Mortenson持有股份的數量也未提供。投資者在考慮做出投資決策時應尋求進一步的細節。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。